- Report
- September 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- May 2024
- 226 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- December 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- January 2025
- 125 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- August 2024
- 141 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- July 2024
- 148 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- September 2024
- 142 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- August 2024
- 170 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2024
- 120 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- April 2024
- 134 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- December 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 166 Pages
Global
From €2377EUR$2,500USD£1,997GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more